Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.
T. Rowe Price Integrated US LCV Eq Adv TQVAX
- NAV / 1-Day Return 17.08 / −0.23 %
- Total Assets 34.4 Mil
-
Adj. Expense Ratio
- Expense Ratio 0.990%
- Distribution Fee Level Above Average
- Share Class Type No Load
- Category Large Value
- Investment Style Large Value
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 0.39%
- Turnover 64%
USD | NAV as of Apr 17, 2024 | 1-Day Return as of Apr 17, 2024, 10:25 PM GMT+0
Morningstar’s Analysis TQVAX
Will TQVAX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 16.2
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
JPMorgan Chase & Co | 3.10 | 1.1 Mil | Financial Services |
Wells Fargo & Co | 1.90 | 666,482 | Financial Services |
Exxon Mobil Corp | 1.69 | 593,056 | Energy |
Citigroup Inc | 1.59 | 559,548 | Financial Services |
Medtronic PLC | 1.38 | 487,081 | Healthcare |
GE Aerospace | 1.35 | 475,862 | Industrials |
Procter & Gamble Co | 1.35 | 473,608 | Consumer Defensive |
Elevance Health Inc | 1.32 | 465,649 | Healthcare |
The Cigna Group | 1.29 | 454,714 | Healthcare |
iShares Russell 1000 Value ETF | 1.27 | 445,984 | — |